MSB 4.00% $1.17 mesoblast limited

Cell Therapy News/Articles, page-8946

  1. 3,097 Posts.
    lightbulb Created with Sketch. 236
    Karen Nichols talks about ‘enlightened consensus’, Ian McNeice talks about ‘other crap’. Seriously. Now I understand why the FDA is being reluctant to push through if this is what is being served up. These doctors, professionals of the FDA are stoic, academic, intelligent, sensitive and aware of the power they hold. Preparation for approval should consider respect for the individuals reviewing before going flat out with the science.

    Alhambra.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.